{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:49:32Z","timestamp":1791672572592,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Osteoarthritis (OA) is increasingly recognized as a disease involving low-grade inflammation and immune remodeling, yet the contribution of the bone marrow (BM) myeloid compartment to hip OA remains poorly defined. Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with immunoregulatory activity and potential roles in inflammatory bone disease. Here, we investigated ex vivo BM myeloid composition and the functional properties of BM-MDSCs in elderly patients with hip OA compared with patients undergoing surgery for proximal femoral fracture. BM aspirates from both cohorts were analyzed by flow cytometry and cultured with G-CSF and GM-CSF to induce BM-MDSCs. Despite the lower mean age of the hip osteoarthritis cohort, these patients showed a significantly higher proportion of BM myeloid cells than fracture patients, whereas lymphoid cell frequencies were not significantly different. Analysis of myeloid maturation stages revealed enrichment of CD11b\u207a\/CD16\n                    <jats:sup>low<\/jats:sup>\n                    metamyelocyte-like cells in hip OA samples both ex vivo and after cytokine-driven expansion. Functional assays demonstrated that inhibition of activated T cell proliferation was confined to the most immature myeloid fraction, which displayed promyelocyte-like features. This suppressive activity was preserved in both hip OA and fracture cohorts, with no significant difference between groups. These findings indicate that hip OA is associated with BM myeloid skewing and selective enrichment of myeloid subsets reassembling metamyelocytes-like cells, while maintaining conserved immunoregulatory function. The BM may represent an active immunological compartment linked to the balance between chronic inflammation and immune regulation in hip OA.\n                  <\/jats:p>","DOI":"10.1007\/s11357-026-02578-0","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:16:19Z","timestamp":1791670579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow myeloid skewing and preserved immunoregulation in hip osteoarthritis of elderly patients"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0687-7834","authenticated-orcid":false,"given":"Ada","family":"Tushe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2657-0496","authenticated-orcid":false,"given":"Eleonora","family":"Binatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1129-2574","authenticated-orcid":false,"given":"Elisa","family":"Belluzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-0363","authenticated-orcid":false,"given":"Assunta","family":"Pozzuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuela","family":"Francescato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7285-2390","authenticated-orcid":false,"given":"Barbara","family":"Buldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-0057","authenticated-orcid":false,"given":"Carlo","family":"Biz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9617-9882","authenticated-orcid":false,"given":"Pietro","family":"Ruggieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0707-995X","authenticated-orcid":false,"given":"Susanna","family":"Mandruzzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"8","key":"2578_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1080\/08820139.2018.1552360","volume":"47","author":"KL Kirkwood","year":"2018","unstructured":"Kirkwood KL, et al. Myeloid-derived suppressor cells at the intersection of inflammaging and bone fragility. Immunol Invest. 2018;47(8):844\u201354.","journal-title":"Immunol Invest"},{"key":"2578_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arr.2018.09.001","volume":"48","author":"A Salminen","year":"2018","unstructured":"Salminen A, Kaarniranta K, Kauppinen A. The role of myeloid-derived suppressor cells (MDSC) in the inflammaging process. Ageing Res Rev. 2018;48:1\u201310.","journal-title":"Ageing Res Rev"},{"key":"2578_CR3","doi-asserted-by":"crossref","unstructured":"Fulop T, et al. Immunosenescence and inflamm-aging as two sides of the same coin: friends or foes? Front Immunol. 2017;8:1960.","DOI":"10.3389\/fimmu.2017.01960"},{"key":"2578_CR4","doi-asserted-by":"crossref","unstructured":"Ross JB, et al. Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity. Nature. 2024;628(8006):162\u201370.","DOI":"10.1038\/s41586-024-07238-x"},{"issue":"6","key":"2578_CR5","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2010.05.010","volume":"32","author":"I Marigo","year":"2010","unstructured":"Marigo I, et al. Tumor-induced tolerance and immune suppression depend on the C\/EBP\u03b2 transcription factor. Immunity. 2010;32(6):790\u2013802.","journal-title":"Immunity"},{"issue":"1","key":"2578_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1189\/jlb.0111021","volume":"90","author":"S Solito","year":"2011","unstructured":"Solito S, Bronte V, Mandruzzato S. Antigen specificity of immune suppression by myeloid-derived suppressor cells. J Leukoc Biol. 2011;90(1):31\u20136.","journal-title":"J Leukoc Biol"},{"key":"2578_CR7","first-page":"47","volume":"1319","author":"S Solito","year":"2014","unstructured":"Solito S, et al. Myeloid-derived suppressor cell heterogeneity in human cancers. Year in Immunology: Myeloid Cells and Inflammation. 2014;1319:47\u201365.","journal-title":"Year in Immunology: Myeloid Cells and Inflammation"},{"key":"2578_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1139683","volume":"14","author":"Y Ren","year":"2023","unstructured":"Ren Y, et al. The role of myeloid derived suppressor cells in musculoskeletal disorders. Front Immunol. 2023;14:1139683.","journal-title":"Front Immunol"},{"issue":"4","key":"2578_CR9","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41423-020-00556-w","volume":"18","author":"L Strauss","year":"2021","unstructured":"Strauss L, et al. Implications of metabolism-driven myeloid dysfunctions in cancer therapy. Cell Mol Immunol. 2021;18(4):829\u201341.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"2578_CR10","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13075-021-02663-z","volume":"23","author":"L Zhang","year":"2021","unstructured":"Zhang L, et al. Expansion of myeloid-derived suppressor cells contributes to metabolic osteoarthritis through subchondral bone remodeling. Arthritis Res Ther. 2021;23(1):287.","journal-title":"Arthritis Res Ther"},{"key":"2578_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/pr11041014","author":"E Belluzzi","year":"2023","unstructured":"Belluzzi E, et al. Human cartilage biomechanics: experimental and theoretical approaches towards the identification of mechanical properties in healthy and osteoarthritic conditions. Processes. 2023. https:\/\/doi.org\/10.3390\/pr11041014.","journal-title":"Processes"},{"issue":"7","key":"2578_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/nrrheum.2016.65","volume":"12","author":"RF Loeser","year":"2016","unstructured":"Loeser RF, Collins JA, Diekman BO. Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(7):412\u201320.","journal-title":"Nat Rev Rheumatol"},{"key":"2578_CR13","doi-asserted-by":"publisher","DOI":"10.21037\/aoj.2019.10.06","author":"N Sandiford","year":"2020","unstructured":"Sandiford N, Kendoff D, Muirhead-Allwood S. Osteoarthritis of the hip: aetiology, pathophysiology and current aspects of management. Ann Joint. 2020. https:\/\/doi.org\/10.21037\/aoj.2019.10.06.","journal-title":"Ann Joint"},{"issue":"1","key":"2578_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/BOR.0000000000000353","volume":"29","author":"CR Scanzello","year":"2017","unstructured":"Scanzello CR. Role of low-grade inflammation in osteoarthritis. Curr Opin Rheumatol. 2017;29(1):79\u201385.","journal-title":"Curr Opin Rheumatol"},{"key":"2578_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051109","author":"MA Terkawi","year":"2022","unstructured":"Terkawi MA, et al. Low-grade inflammation in the pathogenesis of osteoarthritis: cellular and molecular mechanisms and strategies for future therapeutic intervention. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10051109.","journal-title":"Biomedicines"},{"issue":"10","key":"2578_CR16","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/nrrheum.2016.136","volume":"12","author":"WH Robinson","year":"2016","unstructured":"Robinson WH, et al. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2016;12(10):580\u201392.","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"2578_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3899\/jrheum.140382","volume":"42","author":"EW Orlowsky","year":"2015","unstructured":"Orlowsky EW, Kraus VB. The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive. J Rheumatol. 2015;42(3):363\u201371.","journal-title":"J Rheumatol"},{"issue":"8","key":"2578_CR18","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1182\/blood-2010-12-325753","volume":"118","author":"S Solito","year":"2011","unstructured":"Solito S, et al. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood. 2011;118(8):2254\u201365.","journal-title":"Blood"},{"key":"2578_CR19","doi-asserted-by":"crossref","unstructured":"Magri S, et al.\u00a0Human MDSCs derived from the bone marrow maintain their functional ability but have a reduced frequency of induction in the elderly compared to pediatric donors (vol 17, 27, 2020). Immunity & Ageing, 2020. 17(1).","DOI":"10.1186\/s12979-020-00199-5"},{"issue":"11","key":"2578_CR20","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1080\/17435889.2025.2497747","volume":"20","author":"A Tushe","year":"2025","unstructured":"Tushe A, et al. Drug-loaded nanoparticles induce immunogenic cell death and efficiently target cells from glioblastoma patients. Nanomedicine (Lond). 2025;20(11):1223\u201334.","journal-title":"Nanomedicine (Lond)"},{"key":"2578_CR21","doi-asserted-by":"publisher","first-page":"12199","DOI":"10.2147\/IJN.S533321","volume":"20","author":"A Tushe","year":"2025","unstructured":"Tushe A, et al. ZnPPIX-loaded nanoemulsions reprogram immunosuppressive macrophages in vitro: a potential strategy for glioblastoma microenvironment modulation. Int J Nanomedicine. 2025;20:12199\u2013215.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"2578_CR22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/jcla.20001","volume":"18","author":"MT Eighetany","year":"2004","unstructured":"Eighetany MT, et al. Flow cytometric study of neutrophilic granulopoiesis in normal bone marrow using an expanded panel of antibodies: correlation with morphologic assessments. J Clin Lab Anal. 2004;18(1):36\u201341.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"2578_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1182\/blood.V98.4.979","volume":"98","author":"M Stetler-Stevenson","year":"2001","unstructured":"Stetler-Stevenson M, et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood. 2001;98(4):979\u201387.","journal-title":"Blood"},{"issue":"8","key":"2578_CR24","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41577-020-00490-y","volume":"21","author":"F Veglia","year":"2021","unstructured":"Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nat Rev Immunol. 2021;21(8):485\u201398.","journal-title":"Nat Rev Immunol"},{"key":"2578_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-019-0536-x","author":"L Pinton","year":"2019","unstructured":"Pinton L, et al. The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion. J Immunother Cancer. 2019. https:\/\/doi.org\/10.1186\/s40425-019-0536-x.","journal-title":"J Immunother Cancer"},{"key":"2578_CR26","unstructured":"Achakri H. et al. in The National Joint Registry 22nd Annual Report 2025. 2024: London."},{"key":"2578_CR27","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jor.2024.09.005","volume":"61","author":"KC Kim","year":"2025","unstructured":"Kim KC, et al. Comparison of outcomes after total hip arthroplasty in hip fracture versus elective cases in patients over 60 years of age. J Orthop. 2025;61:24\u20137.","journal-title":"J Orthop"},{"issue":"11","key":"2578_CR28","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1001\/jama.2015.10842","volume":"314","author":"Y Le Manach","year":"2015","unstructured":"Le Manach Y, et al. Outcomes after hip fracture surgery compared with elective total hip replacement. JAMA. 2015;314(11):1159\u201366.","journal-title":"JAMA"},{"key":"2578_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5474828","author":"JQ Zhu","year":"2018","unstructured":"Zhu JQ, et al. The expansion of myeloid-derived suppressor cells is associated with joint inflammation in rheumatic patients with arthritis. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/5474828.","journal-title":"Biomed Res Int"},{"key":"2578_CR30","doi-asserted-by":"publisher","first-page":"10235","DOI":"10.2147\/IJGM.S342286","volume":"14","author":"CY Tang","year":"2021","unstructured":"Tang CY, et al. Identification of CIRBP and TRPV4 as immune-related diagnostic biomarkers in osteoarthritis. Int J Gen Med. 2021;14:10235\u201345.","journal-title":"Int J Gen Med"},{"key":"2578_CR31","doi-asserted-by":"crossref","unstructured":"Franceschi C, et al. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018;14(10):576\u201390.","DOI":"10.1038\/s41574-018-0059-4"},{"key":"2578_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102332","author":"ZL Guo","year":"2025","unstructured":"Guo ZL, et al. Harnessing the dual immunomodulatory function of myeloid-derived suppressor cells to reshape the inflammatory microenvironment for osteoarthritis therapy. Mater Today Bio. 2025. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102332.","journal-title":"Mater Today Bio"},{"issue":"11","key":"2578_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41584-018-0073-x","volume":"14","author":"F Berenbaum","year":"2018","unstructured":"Berenbaum F, et al. Modern-day environmental factors in the pathogenesis of osteoarthritis. Nat Rev Rheumatol. 2018;14(11):674\u201381.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"2578_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1158\/0008-5472.CAN-12-2202","volume":"73","author":"A Sawant","year":"2013","unstructured":"Sawant A, et al. Myeloid-derived suppressor cells function as novel osteoclast progenitors enhancing bone loss in breast cancer. Cancer Res. 2013;73(2):672\u201382.","journal-title":"Cancer Res"},{"issue":"12","key":"2578_CR35","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1172\/JCI60920","volume":"122","author":"JF Charles","year":"2012","unstructured":"Charles JF, et al. Inflammatory arthritis increases mouse osteoclast precursors with myeloid suppressor function. J Clin Invest. 2012;122(12):4592\u2013605.","journal-title":"J Clin Invest"},{"issue":"5","key":"2578_CR36","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1093\/rheumatology\/keaa625","volume":"60","author":"SX Chen","year":"2021","unstructured":"Chen SX, et al. Monocytic MDSCs skew Th17 cells toward a pro-osteoclastogenic phenotype and potentiate bone erosion in rheumatoid arthritis. Rheumatology (Oxford). 2021;60(5):2409\u201320.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"2578_CR37","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1609","volume":"13","author":"S Nagaraj","year":"2007","unstructured":"Nagaraj S, et al. Altered recognition of antigen is a mechanism of CD8 T cell tolerance in cancer. Nat Med. 2007;13(7):828\u201335.","journal-title":"Nat Med"},{"issue":"6","key":"2578_CR38","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/S1471-4906(03)00132-7","volume":"24","author":"V Bronte","year":"2003","unstructured":"Bronte V, et al. L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol. 2003;24(6):302\u20136.","journal-title":"Trends Immunol"},{"key":"2578_CR39","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abq6221","author":"S Cane","year":"2023","unstructured":"Cane S, et al. Neutralization of NET-associated human ARG1 enhances cancer immunotherapy. Sci Transl Med. 2023. https:\/\/doi.org\/10.1126\/scitranslmed.abq6221.","journal-title":"Sci Transl Med"},{"issue":"9","key":"2578_CR40","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1172\/JCI80006","volume":"125","author":"S Ugel","year":"2015","unstructured":"Ugel S, et al. Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest. 2015;125(9):3365\u201376.","journal-title":"J Clin Invest"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02578-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02578-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T22:16:20Z","timestamp":1791670580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02578-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":40,"alternative-id":["2578"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02578-0","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Ethics Committee (protocol n\u2009=\u200995\/2015).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all subjects involved in the study. Written informed consent has been obtained from the patients to publish this paper.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Views expressed in the submitted article are from the authors and not form an official position of their institutions.","order":4,"name":"Ethics","label":"Disclosures","group":{"name":"EthicsHeading","label":"Declarations"}}]}}